CAS 136564-68-6: (R)-3-Methoxy-4-[1-methyl-5-[N-(2-methyl-4,4,4-trifluorobutyl)carbamoyl]indol-3-ylmethyl]-N-(2-methylphenylsulfonyl)benzamide

Formule : C₃₁H₃₂F₃N₃O₅S

InChI : InChI=1/C31H32F3N3O5S/c1-19(16-31(32,33)34)17-35-29(38)22-11-12-26-25(14-22)24(18-37(26)3)13-21-9-10-23(15-27(21)42-4)30(39)36-43(40,41)28-8-6-5-7-20(28)2/h5-12,14-15,18-19H,13,16-17H2,1-4H3,(H,35,38)(H,36,39)/t19-/m1/s1

Synonymes :

• Zd-3523
• (R)-3-[2-Methoxy-4-[N-(2-methylphenylsulfonyl)carbamoyl]benzyl]-1-methyl-N-(4,4,4-trifluoro-2-methylbutyl)indole-5-carboxamide
• 3-(2-methoxy-4-{[(2-methylphenyl)sulfonyl]carbamoyl}benzyl)-1-methyl-N-[(2R)-4,4,4-trifluoro-2-methylbutyl]-1H-indole-5-carboxamide
• Zeneca ZD 3523
• Masilukast

1H-Indole-5-carboxamide, 3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-N-[(2R)-4,4,4-trifluoro-2-methylbutyl]-

CAS : 136564-68-6

• Formule : C₃₁H₃₂F₃N₃O₅S
• Degré de pureté : 100%
• Masse moléculaire : 615.6631

Masilukast

CAS : 136564-68-6

Masilukast(MCC-847) is an oral leukotriene D4 (LTD4) receptor antagonist for the study of diseases associated …

• Formule : C₃₁H₃₂F₃N₃O₅S
• Degré de pureté : 99.00% - 99.53%
• Couleur et forme : Solid
• Masse moléculaire : 615.66

3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-N-[(2R)-4,4,4-trifluoro-2-methylbutyl]-1H-indole- 5-carboxamide

CAS : 136564-68-6

3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-N-[(2R)-4,4,4-trifluoro-2- methylbutyl]-1H-indole-5-carboxamide is a hydroxy group containing drug that is activated by techniques such as …

• Formule : C₃₁H₃₂F₃N₃O₅S
• Degré de pureté : Min. 95%
• Masse moléculaire : 615.66 g/mol